Jesse Neri
Directeur Financier/CFO chez ROCKWELL MEDICAL, INC.
Fortune : 50 328 $ au 30/04/2024
Postes actifs de Jesse Neri
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ROCKWELL MEDICAL, INC. | Directeur Financier/CFO | 18/10/2023 | - |
Historique de carrière de Jesse Neri
Anciens postes connus de Jesse Neri
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ZYLA LIFE SCIENCES | Corporate Officer/Principal | 01/06/2015 | - |
Formation de Jesse Neri
| Villanova University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
| Director of Finance/CFO | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ROCKWELL MEDICAL, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA. | Health Technology |
- Bourse
- Insiders
- Jesse Neri
- Expérience